Adaptimmune
3 known investors
Adaptimmune Therapeutics is a biotechnology company, though the specific focus of their therapeutic work is not detailed on this investors and media page.
BiotechHealthtechMedical Devices
Investors · 3
In the news
- Medpathtrial.medpath.com · 2025
- Earnings call: Adaptimmune announces Tecelra launch and solid Q2 results By Investing.cominvesting.com · 2024
- Adaptimmune - 2025 Funding Rounds & List of Investors - Tracxntracxn.com · 2021
- Adaptimmune raises $104 mln to develop immune-system cancer drugs | Avoro Capital Advisorsavorocapital.com · 2014
- Adaptimmune raises US$42m - European Biotechnologyeuropean-biotechnology.com
- Buy Adaptimmune Therapeutics Stock – ADAP Stock Quote Today & Investment Insights - Public.compublic.com